Concepedia

Intranasal ketorolac tromethamine (SPRIX®) containing 6% of lidocaine (ROX-828) for acute treatment of migraine: Safety and efficacy data from a phase II clinical trial

V. Pfaffenrath, E Fenzl, David B. Bregman, Martti Färkkilâ

Cephalalgia · 2012 · 32 citations · 26 references

DOIFull text

Open access

Abstract

Self-administered intranasal ROX-828 was well tolerated. While the primary endpoint was not met, the results provide preliminary evidence that ROX-828 improves migraine pain.

References

26

Prevalence and Burden of Migraine in the United States: Data From the American Migraine Study II

Richard B. Lipton, Walter F. Stewart, Seymour Diamond et al. · Headache The Journal of Head and Face Pain · 2001 · 2.3K citations

Preface to the Second Edition

Jes Olesen · Cephalalgia · 2004 · 2K citations · Full text

, , +2

Terminating Migraine With Allodynia and Ongoing Central Sensitization Using Parenteral Administration of COX1/COX2 Inhibitors

Moshe Jakubowski, Dan Levy, Itay Goor‐Aryeh et al. · Headache The Journal of Head and Face Pain · 2005 · 191 citations · Full text

Treatment patterns of isolated benign headache in US emergency departments

David R. Vinson · Annals of Emergency Medicine · 2002 · 171 citations

, , +4

Terminating migraine with allodynia and ongoing central sensitization using parenteral administration of COX1/COX2 inhibitors

Headache The Journal of Head and Face Pain · 2005 · 159 citations

, , +6